Insider · CIK 0001866792

Buttorff Leslie

CIK 0001866792 Name as filed on the most recent filing

Filed as Buttorff Leslie (13)

68 transaction lines · from 13 filings · filed 2022-02-14 to 2023-09-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

68 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-09-18 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 4,730, acquired Open Form 4 filing 0001493152-23-033155
2023-06-09 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 1,298, acquired Open Form 4 filing 0001493152-23-020928
2023-05-23 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 249, acquired Open Form 4 filing 0001493152-23-018753
2023-05-19 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 2 lines 3,075, acquired Open Form 4 filing 0001493152-23-018753
2023-05-09 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 867, acquired Open Form 4 filing 0001493152-23-016009
2023-05-08 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 645, acquired Open Form 4 filing 0001493152-23-016009
2023-05-05 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 5,635, acquired Open Form 4 filing 0001493152-23-016009
2023-04-26 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 2,187, acquired Open Form 4 filing 0001493152-23-013730
2023-04-25 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 2 lines 1,651, acquired Open Form 4 filing 0001493152-23-013730
2023-04-05 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 825, acquired Open Form 4 filing 0001493152-23-011314
2023-04-04 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 1,120, acquired Open Form 4 filing 0001493152-23-011314
2023-04-03 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 360, acquired Open Form 4 filing 0001493152-23-011314
2023-02-27 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 2 lines 535, acquired Open Form 4 filing 0001493152-23-006398
2023-02-26 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 190, acquired Open Form 4 filing 0001493152-23-006398
2022-12-01 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 95, acquired Open Form 4 filing 0001493152-23-002844
2022-11-29 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 250, acquired Open Form 4 filing 0001493152-23-002844
2022-11-23 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 300, acquired Open Form 4 filing 0001493152-23-002844
2022-09-13 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 101, acquired Open Form 4 filing 0001493152-23-002844
2022-08-26 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 3 lines 2,048, acquired Open Form 4 filing 0001493152-22-024273
2022-08-19 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 1,020, acquired Open Form 4 filing 0001493152-23-002844
2022-08-18 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 170, acquired Open Form 4 filing 0001493152-23-002844
2022-08-11 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 252, acquired Open Form 4 filing 0001493152-23-002844
2022-08-09 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 140, acquired Open Form 4 filing 0001493152-23-002844
2022-08-04 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 8 lines 1,756, acquired Open Form 4 filing 0001493152-22-021447
2022-08-03 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 96, acquired Open Form 4 filing 0001493152-22-021447
2022-07-26 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 132, acquired Open Form 4 filing 0001493152-23-002844
2022-07-22 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 118, acquired Open Form 4 filing 0001493152-23-002844
2022-07-15 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 166, acquired Open Form 4 filing 0001493152-23-002844
2022-07-14 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 89, acquired Open Form 4 filing 0001493152-23-002844
2022-07-11 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 3 lines 1,477, acquired Open Form 4 filing 0001493152-22-019076
2022-07-08 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 2 lines 708, acquired Open Form 4 filing 0001493152-22-019076
2022-06-29 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 750, acquired Open Form 4 filing 0001493152-23-002844
2022-06-21 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 1,443, acquired Open Form 4 filing 0001493152-23-002844
2022-06-17 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 2,707, acquired Open Form 4 filing 0001493152-23-002844
2022-06-16 P, Open-market purchase Panacea Life Sciences Holdings, Inc.PLSH 63, acquired Open Form 4 filing 0001493152-23-002844

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 68
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Buttorff Leslie, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001866792

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.